⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RLAY News
Relay Therapeutics, Inc. Common Stock
Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026
globenewswire.com
RLAY
Form 8-K
sec.gov
RLAY
PFE
Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer
globenewswire.com
RLAY
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
globenewswire.com
RLAY
Form 8-K
sec.gov
RLAY
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
globenewswire.com
RLAY
Form 8-K
sec.gov
RLAY
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
CMPX
MRK
PFE
BOLD
REPL
RDHL
RLAY
LLY
INCY
JAZZ
Form 8-K
sec.gov
RLAY
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
globenewswire.com
RLAY